Incidence and phenotypic characteristics of EBV-associated adenocarcinomas of the upper digestive tract in Lyons area, France;Adénocarcinomes de l'estomac et de l'œsophage distal: Incidence et caractéristiques phénotypiques des cas associés au virus Epstein-Barr (EBV) en région lyonnaise

Annales de Pathologie

Volumn 24, Issue 3, 2004, Pages 228-235

  Kerroucha, Rabah ^a   Hervieu, Valérie ^a   Chambonnière, Marie Laure ^a   Mège Lechevallier, Florence ^a   Poncet, Gilles ^a   Boulez, Jean ^a   Tanière, Philippe ^a   Scoazec, Jean Yves ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Barrett's mucosa; Cancer epidemiology; EBV; Esophageal adenocarcinoma; Gastric adenocarcinoma; In situ hybridization; Tumor markers

Indexed keywords

BETA CATENIN; CYTOKERATIN 20; CYTOKERATIN 7; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; PROTEIN PS2; UVOMORULIN; VIRUS DNA;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER STAGING; EPSTEIN BARR VIRUS; ESOPHAGUS CARCINOMA; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; VIRUS CARCINOGENESIS;

EID: 4444370366     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(04)93957-0     Document Type: Article

References (39)

1. Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000; 53: 255-61.
2. Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990; 80: 77-80.
3. Min KW, Holmquist S, Peiper SC, O'Leary TJ. Poorly differentiated adenocarcinoma with lymphoid stroma (lymphoepithelioma-like carcinomas) of the stomach. Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction. Am J Clin Pathol 1991; 3: 219-27.
4. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992; 96: 769-74.
5. Rowlands DC, Ito M, Mangham DC, Reynolds G, Herbst H, Hallissey MT et al. Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas. Br J Cancer 1993; 2: 1014-9.
6. Shousha S, Luqmani YA. Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa. J Clin Pathol 1994; 47: 695-8.
7. Yuen ST, Chung LP, Leung SY, Luk IS, Chan SY, Ho J. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Surg Pathol 1994; 118: 1158-63.
8. Ott G, Kirchner T, Muller-Hermelink HK. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology 1994; 3: 323-9.
9. zur Hausen A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, van den Brule AJ. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 2000; 60: 2745-8.
10. Tanière P, Martel-Planche G, Maurici D, Lombard-Bohas C, Scoazec JY, Montesano R et al. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol 2001; 158: 33-40.
11. Tanière P, Borghi-Scoazec G, Saurin JC, Lombard-Bohas C, Boulez J, Berger F et al. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am J Surg Pathol 2002; 26: 1213-21.
12. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9.
13. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histochemical classification. Acta Pathol Microbial Scand 1965; 64: 31-49.
14. Hamilton SR, Aaltonen LA, eds. WHO classification of tumours. Tumours of the digestive system. Lyon: IARC Press, 2000. 314 p.
15. Grasser FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W et al. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 1994; 84: 3792-8.
16. Imai S, Usui N, Sugiura M, Osato T, Sato T, Tsutsumi H et al. Epstein-Barr virus genomic sequences and specific antibodies in cerebrospinal fluid in children with neurologic complications of acute and reactivated EBV infections. J Med Virol 1993; 40: 278-84.
17. Marion-Audibert AM, Barel C, Gouysse G, Dumortier J, Pilleul F, Pourreyron C et al. Low microvascular density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 2003; 125: 1094-104.
18. Leoncini L, Vindigni C, Megha T, Funto I, Pacenti L, Musaro M et al. Epstein-Barr virus and gastric cancer: data and unanswered questions. Int J Cancer 1993; 64: 898-901.
19. Selves J, Bibeau F, Brousset P, Meggetto F, Mazerolles C, Voigt JJ et al. Epstein-Barr virus latent and replicative gene expression in gastric carcinoma. Histopathology 1996; 105: 121-7.
20. Chapel F, Fabiani B, Davi F, Raphael M, Tepper M, Champault G et al. Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours. Histopathology 2000; 36: 252-61.
21. Muir CS. Nasopharyngeal carcinoma in non-Chinese populations with special reference to south-east Asia and Africa. Int J Cancer 1971; 8: 351-63.
22. Bouchardy C, Parkin DM, Wanner P, Khlat M. Cancer mortality among north African migrants in France. Int J Epidemiol 1996; 25: 5-13.
23. Mori M, Watanabe M, Tanaka S, Mimori K, Kuwano H, Sugimachi K. Epstein-Barr virus-associated carcinomas of the esophagus and stomach. Arch Pathol Lab Med 1994; 23: 998-1001.
24. Ruschoff J, Dietmaier W, Luttges J, Seitz G, Bocker T, Zirngibl H et al. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol 1997; 71: 1815-25.
25. Kim YS, Paik SR, Kim HK, Yeom BW, Kim I, Lee D. Epstein-Barr virus and CD21 expression in gastrointestinal tumors. Pathol Res Pract 1998; 72: 705-11.
26. Wu MS, Shun CT, Wu CC, Hsu TY, Lin MT, Chang MC et al. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 2000; 118: 1031-8.
27. Koriyama C, Akiba S, Iriya K, Yamaguti T, Hamada GS, Itoh T et al. Epstein-Barr virus-associated gastric carcinoma in Japanese Brazilians and non-Japanese Brazilians in Sao Paulo. Jpn J Cancer Res 2001; 92: 911-7.
28. Chang MS, Lee HS, Kim CW, Kim YI, Kim WH. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract 2001; 197: 395-400.
29. Kattoor J, Koriyama C, Akiba S, Itoh T, Ding S, Eizuru Y et al. Epstein-Barr virus-associated gastric carcinoma in southern India: A comparison with a large-scale Japanese series. J Med Virol 2002; 68: 384-9.
30. Carrascal E, Koriyama C, Akiba S, Tamayo O, Itoh T, Eizuru Y et al. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia. Oncol Rep 2003; 10: 1059-62.
31. Yamamoto N, Tokunaga M, Uemura Y, Tanaka S, Shirahama H, Nakamura T et al. Epstein-Barr virus and gastric remnant cancer. Cancer 1994; 73: 805-9.
32. Nishikawa J, Yanai H, Hirano A, Okamoto T, Nakamura H, Matsusaki K et al. High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction. Scand J Gastroenterol 2002; 37: 825-9.
33. Chiaravalli AM, Cornaggia M, Furlan D, Capella C, Fiocca R, Tagliabue G et al. The role of histological investigation in prognostic evaluation of advanced gastric cancer. Analysis of histological structure and molecular changes compared with invasive pattern and stage. Virchows Arch 2001; 439: 158-69.
34. Ojima H, Fukuda T, Nakajima T, Nagamachi Y. Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas. Jpn J Cancer Res 1997; 55: 262-6.
35. Leung SY, Chau KY, Yuen ST, Chu KM, Branicki FJ, Chung LP. p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma. Histopathology 1998; 33: 311-7.
36. Chang MS, Kim HS, Kim CW, Kim YI, Lan Lee B, Kim WH. Epstein-Barr virus, p53 protein, and microsatellite instability in the adenoma-carcinoma sequence of the stomach. Hum Pathol 2002; 33: 415-20.
37. Ohfuji S, Osaki M, Tsujitani S, Ikeguchi M, Sairenji T, Ito H. Low frequency of apoptosis in Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma. Int J Cancer 1996; 68: 710-5.
38. Kume T, Oshima K, Shinohara T, Takeo H, Yamashita Y, Shirakusa T et al. Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus-associated gastric carcinoma. Histopathology 1999; 34: 502-9.
39. Ishii H, Gobe G, Kawakubo Y, Sato Y, Ebihara Y. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins. Histopathology 2001; 38: 111-9.